PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 17, 2025Journal of Neonatal SurgeryOpen Access

Investigating the Pathophysiology and Treatment Modalities for Autoimmune Disorders

View Full Paper
Ask AI
Bookmark
Share

Authors

HSHarsha SharmaADAndrew T. DeWanNMNaikey Minarey

Discussion

Loading...

Member takes

Overview

Review examines autoimmune disorders' mechanisms and therapies, suggesting biologics and precision medicine may enhance outcomes.

Key Points

  • Biologic therapies, such as infliximab, effectively treat autoimmune disorders like rheumatoid arthritis and systemic lupus erythematosus, showcasing their potential impact.
  • Genetic predisposition and specific HLA alleles are major factors influencing disease onset, highlighting the complexity of autoimmune disorders.
  • This review analyzes literature on cytokines involved in chronic inflammation and evidence of emerging treatment strategies, including JAK inhibitors.
  • Despite advancements in biologics, challenges remain in affordability and access for low-income populations, necessitating ongoing research into novel therapies.

Cite This Study

Sharma et al. (2025) studied this question.

synapsesocial.com/papers/68a36f8a0a429f797333241dhttps://doi.org/10.63682/jns.v14i30s.8167
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Study on Autoimmune Diseases: Etiology, Classification, Diagnosis, and Treatment2025
  2. 2Current Pathogenesis and Treatment of Autoimmune Diseases2024
  3. 3Autoimmune disease: genetic susceptibility, environmental triggers, and immune dysregulation. Where can we develop therapies?2025 · 53 citations
  4. 4Cardiovascular Risk in Autoimmune Diseases: Mechanisms, Management, and Emerging Evidence2025 · 1 citations
  5. 5Targeting Inflammatory Cytokines in Autoimmune Diseases: Mechanisms and Therapeutic Advances with Antibody-Based Therapies2025